COMMUNIQUÉS West-GlobeNewswire

Precision Optics Corporation, Inc. Announces Operating Results for the Second Quarter and Six Months of Fiscal Year 2018

14/02/2018 - 22:30

GARDNER, Mass., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB:PEYE) (the “Company”) today announced operating results on an unaudited basis for its fiscal year 2018 second quarter and six [...]

Xtant Medical Announces Exchange of Outstanding Convertible Notes and Closing of Private Placement

14/02/2018 - 22:30

Exchange of $70.238M (plus interest) of convertible notes into 10,401,309 shares of common stock at $7.20 per share. $6.809M Private Placement representing 945,819 shares of common stock at $7.20 per share. BELGRADE, [...]

Prothena Reports Fourth Quarter and Full Year 2017 Financial Results, and Provides Financial Guidance and R&D Update

14/02/2018 - 22:05

Net cash used in operating and investing activities was $39.9 million in the fourth quarter and $134.7 million for the full year 2017; quarter-end cash and restricted cash position of $421.7 million supports advancement [...]

AGTC Announces Sue Washer, CEO, Elected to Biotechnology Innovation Organization’s Board of Directors

14/02/2018 - 22:05

GAINESVILLE, Fla., and CAMBRIDGE, Mass., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (NASDAQ: AGTC ), a biotechnology company conducting human clinical trials of adeno-associated virus ( [...]

Fluidigm to Participate in Upcoming Health Care Investor Conferences

14/02/2018 - 22:05

SOUTH SAN FRANCISCO, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM ) today announced that the company’s management will participate in two upcoming investor conferences. Chris Linthwaite, [...]

Ultragenyx to Host Conference Call for Fourth Quarter and Full Year 2017 Financial Results and Corporate Update

14/02/2018 - 22:05

NOVATO, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today [...]

Ohr Pharmaceutical Reports Fiscal First Quarter 2018 Financial Results

14/02/2018 - 22:05

NEW YORK, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq: OHRP ), a pharmaceutical company developing therapies for ophthalmic diseases, today reported financial results and operating highlights for [...]

Avid Bioservices Announces Proposed Offering of Common Stock

14/02/2018 - 22:02

TUSTIN, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO ) (NASDAQ: CDMOP ) today announced that it has commenced an underwritten public offering of its common stock. Avid Bioservices also [...]

athenahealth Provides Guidance for Fiscal Year 2018 at its Investor Summit

14/02/2018 - 22:01

WATERTOWN, Mass., Feb. 14, 2018 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ: ATHN ) (“athenahealth” or “we”), a leading provider of network-enabled services for hospital and ambulatory clients nationwide, will host [...]

Amicus Therapeutics Announces Public Offering of Common Stock

14/02/2018 - 22:01

CRANBURY, N.J., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD ) today announced it has commenced a $250 million underwritten public offering of its common stock. J.P. Morgan Securities LLC and [...]

Cytokinetics to Present at the RBC Capital Markets Global Healthcare Conference

14/02/2018 - 22:00

SOUTH SAN FRANCISCO, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK ) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to present a corporate update at [...]

Cutera Reports Fourth Quarter and Full Year 2017 Record Revenue and Financial Results

14/02/2018 - 22:00

Record Fourth Quarter Revenue of $47.6 Million; Increases 26% Year-over-Year; 14 th Consecutive Quarter of Double-Digit Revenue Growth System Revenue Grows in the Fourth Quarter by 35% in North America and 19% [...]

Veloxis Secures USD 60M in Debt Financing

14/02/2018 - 21:36

Company Release no. 01/2018 To: NASDAQ Copenhagen A/S 14 February 2018 Veloxis Secures USD 60M in Debt Financing Cary, NC, February 14, 2018 -- Veloxis Pharmaceuticals A/S (OMX:VELO), a specialty pharmaceutical company [...]

Cannabis Wheaton Income Corp. Extends Warrant Expiry Until February 20, 2018

14/02/2018 - 21:31

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION TO UNITED STATES VANCOUVER, British Columbia, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V: [...]

Nextech Announces Key Expansions to Executive Team

14/02/2018 - 20:56

TAMPA, Fla., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Nextech Systems , a leading provider of health care technology solutions for specialty physician practices, today announces two major updates to its executive leadership [...]

Adventist Health Announces Retirement of CFO Jack Wagner

14/02/2018 - 18:20

ROSEVILLE, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Adventist Health —a faith-based, nonprofit integrated health system serving more than 75 communities in California, Oregon and Hawaii— today announced the planned [...]

MJ Biotech, Inc Corporate Update

14/02/2018 - 18:19

CHEYENNE, Wyo., Feb. 14, 2018 (GLOBE NEWSWIRE) -- MJ Biotech, Inc. (FKA Michael James Enterprises, Inc.) (OTC:MJTV) is in the process of completing its acquisition of Zen Hero, Inc. with the expectation of closing this [...]

Envigo Announces Termination of Transaction Agreement with Avista Healthcare Public Acquisition Corp.

14/02/2018 - 17:34

EAST MILLSTONE, N.J., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Envigo International Holdings, Inc. ("Envigo"), a leading provider of nonclinical contract research services and research models, announced today that the [...]

FIT Biotech Oy: FIT Biotech Ltd's own equity negative in the end of January - Fit Biotech Ltd's own equity to positive with the draw down of a second tranche of financing

14/02/2018 - 17:23

FIT Biotech Oy Company release February 14, 2018 at 6.00 pm EET FIT Biotech Ltd's own equity negative in the end of January - Fit Biotech Ltd's own equity to positive with the draw down of a second tranche of financing [...]